Abk�rzung zur Hauptnavigation Abk�rzung zu den Newsmeldungen Abk�rzung zu den Topstories  
  Barrierefreiheit    Kontakt MedUni Wien    Intranet    MedUni Wien - Shop    Universitätsbibliothek    Universitätsklinikum AKH Wien  
 
ccc_logo_en.gif
 
AKH Wien
 
 
Hauptnavigation
  • Home
  • Über das CCC
    • Allgemeines
    • Leitung der Organisationseinheit
    • CCC-Office Team
    • Kliniken und Partner
    • Qualitätsmanagement
    • Kontakt
  • PatientInnen
    • Covid-19
    • Allgemeines
    • Cancer School
    • Terminvereinbarung
    • Pflegeambulanz
    • PatientInnenvertretung
    • Links
  • Klinischer Bereich
    • Allgemeines
    • CCC Tumorboards
  • Wissenschaft & Forschung
    • Young CCC
    • CCC-ExpertInnenvideos
    • CCC Forschungscluster
    • CCC Units
    • CCC Platforms
    • Translationale Forschung
    • CCC Best Paper Award
    • CCC-TRIO Symposium
    • Kontakt/Links
  • Lehre
    • CCC Cancer School
    • CCC Cancer Update
    • Vienna International Summer School on Clinical and Experimental Oncology - VSSO
    • Interdisziplinäre onkologische Ausbildung
    • Klinisch-Praktisches Jahr (KPJ)
    • PhD Programme
    • Postgraduelle Fort- und Weiterbildung
    • Information/Contact
 
 
Subnavigation
    Inhaltsbereich


    Zurück zur Übersicht
    Frontiers in immunology. 2018 Apr 23. doi: 10.3389/fimmu.2018.00741. pmc: PMC5925867
    Omics-Based Approach Reveals Complement-Mediated Inflammation in Chronic Lymphocytic Inflammation With Pontine Perivascular Enhancement Responsive to Steroids (CLIPPERS).
    Blaabjerg M1,  Hemdrup AL2,  Drici L3,  Ruprecht K4,  Garred P5,  Höftberger R6,  Kristensen BW7,  Kondziella D8,  Sejbaek T9,  Hansen SW10,  Nielsen HH11,  Jensen P12,  Meyer M13,  Paul F14,  Lassmann H15,  Larsen MR16,  Illes Z17
    Author information
    1Department of Neurology, Odense University Hospital, Odense, Denmark.
    2Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark.
    3Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark.
    4Clinical and Experimental Multiple Sclerosis Research Center, Charité - Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
    5Laboratory of Molecular Medicine, Department of Clinical Immunology, Sect. 7631, Rigshospitalet, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
    6Institute of Neurology, Medical University of Vienna, Vienna, Austria.
    7Department of Clinical Research, BRIDGE, University of Southern Denmark, Odense, Denmark.
    8Department of Neurology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
    9Department of Neurology, Odense University Hospital, Odense, Denmark.
    10Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark.
    11Department of Neurology, Odense University Hospital, Odense, Denmark.
    12Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark.
    13Department of Neurology, Zealand University Hospital, Roskilde, Denmark.
    14Clinical and Experimental Multiple Sclerosis Research Center, Charité - Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
    15Center for Brain Research, Medical University of Vienna, Vienna, Austria.
    16Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark.
    17Department of Neurology, Odense University Hospital, Odense, Denmark.
    Abstract

    OBJECTIVE: Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) is a rare syndrome with relapsing brainstem/cerebellar symptoms. To examine the pathogenic processes and investigate potential biomarkers, we analyzed combined materials of brain and cerebrospinal fluid (CSF) by comprehensive methodologies.

    MATERIALS AND METHODS: To identify major pathways of perivascular inflammation in CLIPPERS, we first compared the CSF proteome ( = 5) to a neurodegenerative condition, Alzheimer's disease (AD,  = 5). Activation of complement was confirmed by immunohistochemistry (IHC) on CLIPPERS brain samples ( = 3) and by ELISA in the CSF. For potential biomarkers, we used biomarker arrays, and compared inflammatory and vessel-associated proteins in the CSF of CLIPPERS ( = 5) with another inflammatory relapsing CNS disease, multiple sclerosis (RMS,  = 9) and healthy subjects (HS,  = 7).

    RESULTS: Two hundred and seven proteins in the CSF discriminated CLIPPERS from AD. The complement cascade, immunoglobulins, and matrix proteins were among the most frequently represented pathways. Pathway analysis of upstream regulators suggested the importance of vascular cell adhesion protein 1 (VCAM1), IFN-γ, interleukin (IL)-1, and IL-10. Differential regulation of more than 10 complement proteins of the 3 complement pathways in the CSF pointed to the role of complement activation. IHC on brain samples confirmed the perivascular complement activation, i.e., deposition of C3bc, C3d, and the terminal C5b-9 complement complex that partially overlapped with accumulation of IgG in the vessel wall. Besides endothelial cell damage, reactivity to smooth muscle actin was lost in the walls of inflamed vessels, but the glia limitans was preserved. The semi-quantitative array indicated that increased level of IL-8/CXCL8 ( < 0.05), eotaxin/CCL11 ( < 0.01), and granulocyte colony-stimulating factor ( < 0.05) in CSF could distinguish CLIPPERS from HS. The quantitative array confirmed elevated concentration of IL-8/CXCL8 and eotaxin/CCL11 compared to HS ( < 0.05, respectively) besides increased levels of ICAM-1 ( < 0.05) and VCAM-1 ( < 0.001). The increased concentration of VCAM-1 were able to differentiate CLIPPERS from RMS ( < 0.01), and a trend of elevated levels of ICAM-1 and IL-8/CXCL8 compared to RMS was also observed ( = 0.06, respectively).

    CONCLUSION: Complement activation, IgG deposition, and alterations of the extracellular matrix may contribute to inflammation in CLIPPERS. VCAM1, ICAM1, and IL-8 in the CSF may differentiate CLIPPERS from RMS.


    KEYWORDS: CLIPPERS, ICAM-1, VCAM-1, cerebrospinal fluid, complement, interleukin-8, multiple sclerosis, proteomics

    Publikations ID: 29740431
    Quelle: öffnen
     
    Drucken
     
    ccc_logo_en.gif
    ccc_logo_en.gif
    ccc_logo_en.gif

    Schnellinfo

     
    -- Initiative Krebsforschung / Krebsforschungslauf

    -- Cancer Care
    -- Kliniken und Partner
    -- CCC Cancer School
    -- Young CCC
    -- CCC Tumorboards
    -- CCC Forschungscluster
    -- CCC Units
    -- CCC Platforms
    -- SOPs / Leitlinien
    -- Kontakt
    Zuklappen
     
    Ausklappen
     
     

    Featured

     
     
     
     
     
     
     
     
     
     
     
     
     
    © MedUni Wien |
     Impressum | Nutzungsbedingungen | Kontakt